Literature DB >> 1848546

Platelet aggregation induced by adenosine diphosphate released from cloned murine fibrosarcoma cells is positively correlated with the experimental metastatic potential of the cells.

Y Mogi1, K Kogawa, T Takayama, N Yoshizaki, K Bannai, H Muramatsu, K Koike, Y Kohgo, N Watanabe, Y Niitsu.   

Abstract

We established five clones (ML-01, ML-02, MH-01, MH-02, MH-03) from murine 3-methylcholanthrene-induced fibrosarcoma A (Meth A), and investigated their experimental metastatic potentials in relation to their platelet-aggregating activities. A clone with a high metastatic potential (MH-02) showed a characteristic biphasic pattern of platelet aggregation, of which the first peak was not present in the aggregation patterns of the clone with low metastatic potential (ML-01). The first peak was eliminated by treatment of the cells with apyrase, indicating that adenosine diphosphate (ADP) was the causative substance of this particular peak. The metastatic potential of clones correlated well with the ADP concentration of the culture media. These results suggest that the increased ADP production and consequential enhancement of platelet-aggregating activity are closely related to the increment of pulmonary metastatic potential of MH-02 clone.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1848546      PMCID: PMC5918379          DOI: 10.1111/j.1349-7006.1991.tb01828.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


3‐methylcholanthrene‐induced fibro‐sarcoma A adenosine diphosphate fetal calf serum phosphate‐buffered saline platelet‐rich plasma platelet‐poor plasma
  23 in total

1.  Involvement of platelet membrane glycoprotein Ib and glycoprotein IIb/IIIa complex in thrombin-dependent and -independent platelet aggregations induced by tumor cells.

Authors:  H Kitagawa; N Yamamoto; K Yamamoto; K Tanoue; G Kosaki; H Yamazaki
Journal:  Cancer Res       Date:  1989-02-01       Impact factor: 12.701

2.  Antimetastatic effects associated with platelet reduction.

Authors:  G J Gasic; T B Gasic; C C Stewart
Journal:  Proc Natl Acad Sci U S A       Date:  1968-09       Impact factor: 11.205

3.  Tumor cell-platelet aggregation: induced by cathepsin B-like proteinase and inhibited by prostacyclin.

Authors:  K V Honn; P Cavanaugh; C Evens; J D Taylor; B F Sloane
Journal:  Science       Date:  1982-08-06       Impact factor: 47.728

4.  Correlation between spontaneous metastatic potential, platelet-aggregating activity of cell surface extracts, and cell surface sialylation in 10 metastatic-variant derivatives of a rat renal sarcoma cell line.

Authors:  E Pearlstein; P L Salk; G Yogeeswaran; S Karpatkin
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

5.  Some characteristics of mouse platelet aggregation and a comparison of the activity of a range of compounds in mouse and human platelet-rich plasma in vitro.

Authors:  B Nunn
Journal:  Thromb Haemost       Date:  1981-02-23       Impact factor: 5.249

6.  [Studies on platelet aggregation induced by human cultured carcinoma cell lines].

Authors:  Y Niitsu; Y Mogi; K Bannai; B Ishii; S Ishigaki; R Kumai; Y Koshida; K Kogawa; Y Kohgo; I Urushizaki
Journal:  Gan To Kagaku Ryoho       Date:  1984-03

7.  Identification of a platelet-aggregating factor of murine colon adenocarcinoma 26: Mr 44,000 membrane protein as determined by monoclonal antibodies.

Authors:  M Watanabe; E Okochi; Y Sugimoto; T Tsuruo
Journal:  Cancer Res       Date:  1988-11-15       Impact factor: 12.701

8.  Inhibition of the platelet-aggregating activity of two human adenocarcinomas of the colon and an anaplastic murine tumor with a specific thrombin inhibitor, dansylarginine N-(3-ethyl-1,5-pentanediyl)amide.

Authors:  E Pearlstein; C Ambrogio; G Gasic; S Karpatkin
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

9.  Platelet-cancer cell interaction in metastasis formation: a possible therapeutic approcach to metastasis prophylaxis.

Authors:  H Gastpar
Journal:  J Med       Date:  1977

10.  The role of blood platelets in experimental metastases.

Authors:  P Hilgard
Journal:  Br J Cancer       Date:  1973-11       Impact factor: 7.640

View more
  5 in total

1.  Enhanced inhibition of experimental metastasis by the combination chemotherapy of Cu-Zn SOD and adriamycin.

Authors:  K Kogawa; H Muramatsu; M Tanaka; Y Nishihori; S Hagiwara; K Kuribayashi; K Nakamura; K Koike; S Sakamaki; Y Niitsu
Journal:  Clin Exp Metastasis       Date:  1999-05       Impact factor: 5.150

2.  Significance of platelets in an antimetastatic activity of bacterial lipopolysaccharide.

Authors:  M Kimoto; K Ando; S Koike; T Matsumoto; T Jibu; H Moriya; S Kanegasaki
Journal:  Clin Exp Metastasis       Date:  1993-05       Impact factor: 5.150

3.  Enhanced expression of type IV collagen-binding protein (p29) in Fyn-transfected murine fibrosarcoma cells.

Authors:  Kazuhiko Koike; Katsuhisa Kogawa; Tetsuji Takayama; Naohito Yoshizaki; Hirohito Muramatsu; Kiminori Nakamura; Sumio Sakamaki; Yoshiro Niitsu
Journal:  Jpn J Cancer Res       Date:  2002-10

4.  ED-110, a novel indolocarbazole, prevents the growth of experimental tumors in mice.

Authors:  H Arakawa; T Iguchi; T Yoshinari; K Kojiri; H Suda; A Okura
Journal:  Jpn J Cancer Res       Date:  1993-05

5.  Augmented expression of a type IV collagen-binding protein in a highly metastatic murine fibrosarcoma clone.

Authors:  K Kogawa; Y Mogi; T Takayama; K Koike; N Yoshizaki; H Muramatsu; Y Niitsu
Journal:  Jpn J Cancer Res       Date:  1993-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.